MILRINONE Drug Patent Profile
✉ Email this page to a colleague
When do Milrinone patents expire, and what generic alternatives are available?
Milrinone is a drug marketed by Baxter Hlthcare Corp, Caplin, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hikma Farmaceutica, Hospira, Intl Medicated, Meitheal, Mylan Institutional, Shandong, Eugia Pharma, Woodward, B Braun, Baxter Hlthcare, and Gland. and is included in twenty-six NDAs.
The generic ingredient in MILRINONE is milrinone lactate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Milrinone
A generic version of MILRINONE was approved as milrinone lactate by FRESENIUS KABI USA on May 28th, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MILRINONE?
- What are the global sales for MILRINONE?
- What is Average Wholesale Price for MILRINONE?
Summary for MILRINONE
| US Patents: | 0 |
| Applicants: | 16 |
| NDAs: | 26 |
| Drug Prices: | Drug price information for MILRINONE |
| DailyMed Link: | MILRINONE at DailyMed |
US Patents and Regulatory Information for MILRINONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Woodward | MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 077151-001 | Jul 20, 2005 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 078113-001 | May 21, 2008 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma Farmaceutica | MILRINONE LACTATE IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 090038-001 | Jan 21, 2010 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
